Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, September 9, 2025.
PharmaCyte Biotech, Inc. (NASDAQ:PMCB)
Strong Uptrend (+100) - PMCB is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, PMCB continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid PMCB?
MarketClub looks at technical strength and momentum to determine if the timing is right for PMCB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for PMCB
The long-term trend has been UP since Sep 8th, 2025 at 1.15
The intermediate-term trend has been UP since Aug 19th, 2025 at 1.05
The short-term trend has been UP since Sep 8th, 2025 at 0.99
Smart Scan Analysis for PMCB
Based on our trend formula, PMCB is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.9700 | 1.2520 | 0.9450 | 1.1100 | +0.1689 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.9411 | 522054 | 2025-09-08 15:59:41 |
| Year High | 0.105 | Year High Date | 2018-06-13 |
| Year Low | 0.045 | Year Low Date | 2018-11-29 |
| 52wk High | 2.4229 | 52wk High Date | 2024-10-30 |
| 52wk Low | 0.8 | 52wk Low Date | 2025-08-06 |
| Average Volume | 118,099 | Shares Outstanding | 6,796 |
| Assets | 55,168,353M | Liabilities | 3,277,284M |
| P/E Ratio | 0.295 | Volatility | 47.11 |